CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	6 Months Ended
	Feb. 28, 2026	Feb. 28, 2025
Operating Activities
Net (loss) earnings	$ 35,439	$ 42,624
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation and amortization	8,784	6,985
Stock-based compensation expense	5,916	6,186
Provision for deferred income taxes	3,085	3,089
Amortization of debt issuance costs	293	293
Other Noncash Income (Expense)	145	(15)
Increase in Receivable Reserve	295	0
Changes in components of working capital and other, excluding acquisitions and divestitures:
Accounts receivable	(3,571)	(6,830)
Inventories	(12,611)	(9,426)
Trade accounts payable	(994)	(1,658)
Prepaid expenses and other assets	(4,354)	(5,224)
Income tax accounts	(273)	(5,297)
Accrued compensation and benefits	(8,711)	(6,170)
Other accrued liabilities	5,584	(8,449)
Investing Activities
Capital expenditures	(5,734)	(11,517)
Payments to Acquire Businesses, Net of Cash Acquired	0	27,196
Payment for Contingent Consideration Liability, Investing Activities	949	0
Financing Activities
Borrowings on Revolving Credit	14,000	14,421
Principal Repayment on Revolving Credit Facility	(14,000)	(14,421)
Principal repayments on term loan	(2,500)	(2,500)
Cash dividend	(2,119)	(2,167)
Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation	156	89
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Total	(52,839)	(47,585)
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation	98,719	119,509
Payments for Repurchase of Common Stock	(65,924)	(14,555)
Stock options, taxes paid related to the net share settlement of equity awards and other	(4,796)	(5,847)
Cash used in financing activities	(75,339)	(25,069)
Cash Provided by Investing Activities	(6,683)	(38,713)
Cash (Used in) Provided By Operating Activities	$ 29,027	$ 16,108